Journey Medical Corporation (DERM)
NASDAQ: DERM · IEX Real-Time Price · USD
5.46
-0.05 (-0.91%)
At close: Jul 19, 2024, 4:00 PM
5.44
-0.02 (-0.37%)
Pre-market: Jul 20, 2024, 9:28 AM EDT
Journey Medical Stock Forecast
Stock Price Forecast
The 3 analysts with 12-month price forecasts for Journey Medical stock have an average target of 8.50, with a low estimate of 6.00 and a high estimate of 11. The average target predicts an increase of 55.68% from the current stock price of 5.46.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for DERM stock from 3 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Feb '24 | Mar '24 | Apr '24 | May '24 | Jun '24 | Jul '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 3 | 3 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 2 | 2 | 2 | 2 | 3 | 3 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Roth MKM | Roth MKM | Strong Buy Initiates $11 | Strong Buy | Initiates | $11 | +101.47% | Jun 28, 2024 |
| Alliance Global Partners | Alliance Global Partners | Strong Buy Initiates $8.5 | Strong Buy | Initiates | $8.5 | +55.68% | Feb 16, 2024 |
| B. Riley Securities | B. Riley Securities | Strong Buy Reiterates $6 | Strong Buy | Reiterates | $6 | +9.89% | Sep 7, 2023 |
| B. Riley Securities | B. Riley Securities | Strong Buy Maintains $3 → $6 | Strong Buy | Maintains | $3 → $6 | +9.89% | Jul 12, 2023 |
| B. Riley Securities | B. Riley Securities | Strong Buy Maintains $6 → $3 | Strong Buy | Maintains | $6 → $3 | -45.05% | May 23, 2023 |
Financial Forecast
Revenue This Year
57.95M
from 79.18M
Decreased by -26.81%
Revenue Next Year
82.01M
from 57.95M
Increased by 41.50%
EPS This Year
-0.95
from -0.21
EPS Next Year
-0.24
from -0.95
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | 61.0M | 105.1M | 80.3M |
| Avg | 58.0M | 82.0M | 78.0M |
| Low | 54.4M | 59.5M | 74.9M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | -22.9% | 81.3% | -2.1% |
| Avg | -26.8% | 41.5% | -4.9% |
| Low | -31.3% | 2.7% | -8.6% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | -0.89 | 0.21 | -0.25 |
| Avg | -0.95 | -0.24 | -0.24 |
| Low | -1.00 | -0.67 | -0.24 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | - | - | - |
| Avg | - | - | - |
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.